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Abstract 
Background: Plasmodium vivax is the most widely distributed human malaria parasite and accounts for approxi-
mately the same number of malaria cases as Plasmodium falciparum in India. Compared with P. falciparum, P. vivax is 
difficult to eradicate because of its tendency to cause relapses, which impacts treatment and control strategies. The 
genetic diversity of these parasites, particularly of the merozoite surface protein-3 alpha (msp-3α) gene, can be used 
to help develop a potential vaccine. The present study aimed to investigate the genetic diversity of P. vivax using 
the highly polymorphic antigen gene msp-3α and to assess the suitability of using this gene for population genetic 
studies of P. vivax isolates and was carried out in 2004–06. No recent study has been reported for MSP 3α in the recent 
decade in India. Limited reports are available on the genetic diversity of the P. vivax population in India; hence, this 
report aimed to improve the understanding of the molecular epidemiology of the parasite by studying the P. vivax 
msp-3α (Pvmsp-3α) marker from P. vivax field isolates from India.
Methods: Field isolates were collected from different sites distributed across eight states in India. A total of 182 blood 
samples were analysed by a nested polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) 
technique using the HhaI and AluI restriction enzymes to determine genetic msp-3α variation among clinical P. vivax 
isolates.
Results: Based on the length variants of the PCR products of Pvmsp-3α gene, three allele sizes, Type A (1.8 kb), Type 
B (1.5 kb) and Type C (1.2 kb) were detected among the 182 samples. Type A PCR amplicon was more predominant 
(75.4 %) in the samples compared with the Type B (14.3 %) and Type C (10.0 %) polymorphisms. Among all of the sam-
ples analysed, 8.2 % were mixed infections detected by PCR alone. Restriction fragment length polymorphism (RFLP) 
analysis involving the restriction enzymes AluI and HhaI generated fragment sizes that were highly polymorphic and 
revealed substantial diversity at the nucleotide level.
Conclusions: The present study is the first extensive study in India using the Pvmsp-3α marker. The results indicated 
that Pvmps-3α, a polymorphic genetic marker of P. vivax, exhibited considerable variability in infection prevalence in 
field isolates from India. Additionally, the mean multiplicity of infection observed at all of the study sites indicated that 
P. vivax is highly diverse in nature in India, and Pvmsp-3α is likely an effective and promising epidemiological marker.
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Background
Plasmodium vivax is the most widely spread human 
malaria parasite, infecting 22 million people each year 
outside of sub-Saharan Africa. Plasmodium vivax has a 
firm hold in South and Southeast Asia, where it accounts 
for 80  % of the total estimated cases from three coun-
tries: India, Indonesia and Pakistan [1]. Although P. 
vivax malaria is acute and excruciating, it is considered 
a benign form of tertian fever with fewer complications 
compared with Plasmodium falciparum [2]. However, 
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recent evidence has indicated the occurrence of com-
plicated vivax malaria cases, especially in Asia [3, 4]. 
The problem is further compounded by the emergence 
of drug resistance in vivax malaria [5–12]. The partial 
effectiveness of drug treatments and subsequent recur-
rent infections contribute to severe anaemia from vivax 
malaria [13].
In India, high endemicity in conjunction with the dense 
population contributes to the burden of vivax malaria, 
leading to vast social and economic consequences. Recent 
reports indicated equal prevalence of both P. vivax and P. 
falciparum in India [14]. Despite its prevalence, the lack 
of knowledge regarding global endemicity is a major hin-
drance to controlling vivax malaria [15]. Investigating the 
parasite population structure for genetic polymorphisms 
could aid in understanding the role of genetic diversity in 
malaria transmission [16] and is essential for the control 
and elimination of malaria [17].
Despite the high prevalence of P. vivax, few stud-
ies have investigated the genetic diversity of natural P. 
vivax populations in India. The P. vivax genome exhibits 
greater diversity compared with P. falciparum [18] and 
displays high levels of antigenic polymorphisms, which 
indicates the presence of sophisticated mechanisms to 
evade the human immune system [19]. However, recur-
rent infections that arise from recrudescence, re-infec-
tion or relapses make it difficult to interpret the results of 
clinical P. vivax studies that aim to determine the efficacy 
of treatment strategies.
Elucidating the genetic diversity of Indian P. vivax iso-
lates using antigenic markers could augment the under-
standing of the biology and epidemiology of P. vivax. 
Additionally, understanding host genetics and environ-
mental conditions will further aid in developing strate-
gies for the effective control of malaria. To date, a number 
of single-copy antigenic genetic markers have been tested 
and reported for Indian isolates [20–24].
The gene of the P. vivax merozoite surface protein-3 
alpha (Pvmsp-3α) is one of the most commonly charac-
terized molecular markers in P. vivax genotyping studies. 
Pvmsp-3α is a potentially an important vaccine candi-
date expressed on the merozoite surface of the parasite 
and encodes a protein with three blocks of alanine-rich 
domain containing heptad repeats and is predicted 
to form α-helical coiled-coil tertiary structures  [25]. 
Sequence polymorphism is concentrated in the  central 
domain and can comprise of numerous point muta-
tions and large insertions and deletions  [26, 27]. These 
polymorphisms confer antigenic diversity in Pvmsp-3α; 
however, the alanine-rich heptad repeats, which are pre-
dicted to form an intramolecular coiled-coil, are con-
served [28]. The msp3 paralogs from P. vivax show weak 
similarity to msp3 gene family members on P. falciparum 
[29]. Although both PfMSP-3 and PvMSP-3 protein con-
tain blocks of alanine-rich heptad repeats followed by an 
acidic C-terminus [30], there is no supporting evidence 
of msp3  family of  P. falciparum  being a homologue to 
that of  P. vivax [28]. In India, this polymorphic marker 
has been characterized in Kolkata, which is a hypo-
endemic region [20], and in Chennai, which exhibits 
variable endemicity [21] and extensive polymorphisms in 
the single-copy gene and encoded protein. High genetic 
diversity in this locus has also been reported in South 
and Southeast Asian countries, including Korea [31], 
Nepal [32], Pakistan [33, 34], Bangladesh [35], Sri Lanka 
[36] and Thailand [37].
Studying the pattern of variation and distribution of 
Pvmsp-3α polymorphisms in different blocks of MSP-3α 
among isolates of South Asia and around the world will 
aid in understanding of the evolutionary mechanisms 
underlying variation patterns [38]. Studies on genetic 
variation in different regions with malaria have revealed 
numerous alleles and specific variants in different 
MSP-3α blocks. Additionally, the allelic forms in different 
blocks were observed in diverse populations worldwide 
[39–43]. PvMSP3α  is composed of four regions which 
include an N-terminal signal sequence, polymorphic ala-
nine rich repeat region as block I, less variable region as 
block II and an acidic C-terminus. Deletion within block 
I region is the basis of size polymorphism in msp-3α 
whereas in block II, the variations was clustered around 
the two structural motifs (motif I: MSELEK/LSKLEE and 
motif II: TAANVVKD/KEATAAKL) [26, 38, 44]. Among 
different populations block II was found to be relatively 
conserved with synonymous and non-synonymous muta-
tions. Synonymous mutations were seen in low frequency 
and were population specific however, non-synonymous 
mutations were extensively shared among different para-
site populations [38]. Restriction fragment length poly-
morphism (RFLP) analysis was used to determine the 
diversity of this gene using sequenced representative 
isolates. Patterns and levels of genetic diversity provide 
insight into population structure and aid in testing for 
balancing or negative selection acting on this gene.
Analysing P. vivax population structure is fundamen-
tal to understanding the role of genetic diversity in the 
transmission of malaria. Moreover, knowledge of the 
magnitude of the genetic polymorphisms within P. vivax 
populations is an important element for the development 
of strategies to effectively control malaria [45]. Pvmsp-3α 
is a potential antigen for vaccine development, as indi-
cated by a study of small children in a malaria-endemic 
region, Papua New Guinea (PNG) [46]. Variation in 
the msp-3α allelic patterns of P. vivax in India provides 
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fundamental knowledge for inferring P. vivax population 
structure and therefore information that can be used to 
help design MSP-3-based malaria vaccines.
In this paper the extent of allelic and sequence diver-
sity in Pvmsp-3α in field isolates collected from different 
geographical regions of India with varied malaria trans-
mission patterns was investigated. To accomplish this, 
isolates from different endemic areas were collected and 
amplified by nested polymerase chain reaction (PCR) and 
analysed using PCR-RFLP analysis.
Methods
Study sites
Blood samples were collected between 2000 and 2004 
during spot surveys from patients who attended malaria 
diagnosis clinics at the Malaria Research Centre head-
quarters in Delhi or within field units. A total of 182 
finger-prick blood samples were obtained from indi-
viduals from eight different geographical regions of 
the Indian sub-continent, including coastal, mainland 
and island regions (Fig.  1). In the northern region of 
the country, samples were collected from Delhi, Panna 
(Madhya Pradesh) and Nadiad (Gujarat). The Anopheles 
culicifacies vector is the primary vector in this region, 
and transmission is mainly in the post-monsoon months 
(July–October). The blood samples were collected during 
malaria outbreaks in all study sites except Delhi. Samples 
were collected from rural settings in Nadiad, and tribal 
dominant forest ecotypes in Panna. Sundergarh (Orissa), 
a tribal-dominated area under the influence of the highly 
anthropophagic vector Anopheles fluviatilis, is a hyper-
endemic district within the state of Orissa, which has 
reported more than 90  % of known falciparum malaria 
cases. Navi Mumbai (Maharashtra), Goa and Chennai 
(Tamil Nadu) are all coastal regions in which P. vivax 
is dominant. In Chennai, which is located on the east-
ern coast of India, Anopheles stephensi is a major vector 
in urban areas, whereas An. stephensi and An. culicifa-
cies are responsible for the transmission of malaria in 
Goa and Navi Mumbai (on the western coast). On Car 
Nicobar Island (Bay of Bengal), Anopheles sundaicus is 
the primary endemic vector of malaria, but reports of 
Fig. 1 Map of India indicating the study sites and graphic representation of the geographical distribution of the frequencies of the Pvmsp-3α haplo-
types in isolates from the Indian sub-continent
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perennial transmissions by P. vivax and P. falciparum 
occur throughout the year.
The blood smears were stained with Jaswant Singh 
Bhattacharya stain [47] and examined under 1000× mag-
nification. The samples collected were spotted onto auto-
claved Whatman filter paper (3  mm) strips, and dried 
blood spots were stored at 4 °C in plastic bags prior to the 
extraction of parasite DNA. The study was approved by 
the ethics committee of the National Institute of Malaria 
Research. Informed consent was obtained from all adult 
participants and from the legal guardians of minors.
Genomic DNA isolation
Extraction of parasite genomic DNA from individual 
dried blood spots on Whatman filter paper strips was 
carried out using the QiAamp DNA extraction mini kit 
(Qiagen, Hilden, Germany) based on the manufacturer’s 
instructions. Extracted samples were re-dissolved in 
100 μl triple-distilled autoclaved water and used as a tem-
plate for PCR amplification or stored at −20 °C until use.
Pvmsp‑3α PCR analysis
Plasmodium vivax genotyping was carried out using 
a nested PCR assay. The protocols used for the PCR 
assays were reported by Bruce et al. [48]. A 5-µl aliquot 
of each PCR product was visualized on a 1 % agarose gel 
(Boehringer Mannheim, Indianapolis, USA). Only the 
samples showing single a PCR fragment were considered 
for RFLP analysis.
RFLP analysis
Characterization of the allelic patterns of the 167 PCR 
single clone isolates obtained was performed using the 
AluI and HhaI restriction enzymes based on the methods 
reported by Bruce et  al. [48]. To determine the level of 
Pvmsp-3α polymorphism, RFLP analysis was carried out 
using the HhaI and AluI restriction enzymes (NEB, Inc, 
Beverly, MA, USA) in a 10-µL reaction volume. A 5-µl 
aliquot of each PCR product was digested individually 
with the restriction enzymes along with BSA in the buffer 
supplied with the enzymes at 37  °C for 4 h. The restric-
tion products were then visualized on a 3.0 % agarose gel.
DNA sequencing
Twenty isolates that represented all three of the vari-
ants were sequenced and subjected to restriction pat-
tern analysis. These included six samples each of Type 
B and C and 8 samples of Type A. Conserved primers 
were designed for nested PCR amplifications to target 
the block-I, beta, and block-II regions that covered the 
entire alanine-rich region of Pvmsp-3α [43], which cor-
responded to nucleotide positions 205  bp to 2,100  bp 
(69–700 aa) of the Belem strain [27]. The nested PCR 
products that were sequenced were subjected to in silico 
simulation using a restriction mapper [49] to map the 
restriction sites and generate fragment sizes. The ampli-
fied PCR products from a limited number of isolates from 
each area were sequenced using the BigDye® terminator 
cycle sequencing Kit (Applied Biosystems, Foster City, 
CA, USA) and the ABI Prism® 310 Genetic Analyzer 
(Applied Biosystems). Curation was performed using 
the ABI Prism® sequence analysis software (version 3.4, 
Applied Biosystems). Six internal primers were designed 
using the Belem strain as a standard to cover the 1.8-kb 
length and sequenced in both directions for accuracy. 
The following primers were used: sense strand primers, 
including Pvmsp3α_F1, 5′-CCGGAAATGCCAACAA-3′; 
Pvmsp3α_F2, 5′-CAAAGGCGGAAGTGCTGAAC-3′; 
Pvmsp3α_F3: 5′-GAGAAAAAGCAGAAAA.
GGTAGGAG-3′; and anti-sense primers, including 
Pvmsp3α_R1, 5′-CCGCCTTTTCCTTTGCCTTAATTT 
G-3′; Pvmsp3α_R2, 5′-GCCTTTTCTG CCTGCTTCT 
TA-3′; and Pvmsp3α_R3, 5′-TGCTTTATTTTTAGTTTC 
TTGTGG-3′. In addition, two nested primers, N1 and 
N2, were used as described by Bruce et al. [48].
Pvmsp‑3α sequence and phylogenetic analysis
The resulting nucleotide sequences, amino acid 
sequences that were subsequently deduced from the 
nucleotide sequences, and multiple sequence alignments 
were analysed using MEGA 6.06 [50, 51], and the aligned 
sequences were analysed for phylogenetic inference. To 
determine the details of Pvmsp-3α sequence diversity, 
PCR products of 20 samples were aligned with the Belem 
I reference gene (AF093584) and Salvador I sequence 
(AAO20890). Restriction site analysis of the Pvmsp-3α 
sequences from various geographical regions was carried 
out using restriction-mapping software [49]. The Indian 
isolates were also compared with 80 published Pvmsp-3α 
sequences from isolates from different geographic loca-
tions including India (KC935446, AF491957, HQ328853-
55), Bangladesh (AF491951, AAO20882), Sri Lanka 
(AF491961 and GU175269-72), Pakistan (AY266090), 
Thailand (AY833010-26), North Korea (AF491958), 
South Korea (EF204144-63), Myanmar (EU430576-86), 
PNG (AF491950, AF491959), Borneo AY118174), Ven-
ezuela (KC935422-26), Ecuador (AF491952), Belem 
(AF093584), and Sal_I (AAO20890). Evolutionary rela-
tionships of the Indian isolates and published Pvmsp-3α 
sequences were determined based on the construction 
of a phylogenetic tree of nucleotide sequences using the 
reference strains and the maximum likelihood method, 
which is based on the Kimura two-parameter distance 
estimation method [51] using Mega 6.06. To obtain a 
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confidence value for the aligned sequence dataset, boot-
strap analysis of 1000 replications was conducted using 
Mega 6.06.
Ethical clearance
Study has clearance of Ethics committee of National 
Institute of Malaria Research.
Results
Pvmsp3‑α allelic frequency
A total of 182 P. vivax-positive samples confirmed by 
microscopy were further investigated by PCR. Pvmsp3-α 
exhibited a high level of genetic diversity among the field 
isolates collected from the different study areas. PCR 
analyses of the isolates from the eight different sites in 
India revealed the presence of three variants of differ-
ent lengths: Type A (1.8 kb), Type B (1.4 kb) and Type C 
(1.2 kb), which were observed in isolates from across the 
study sites, and Type A variant among the isolates was 
the most prevalent (Table 1). The geographical distribu-
tion of the Pvmsp-3α variant frequencies of the isolates 
from the Indian sub-continent is shown in Fig. 1. The fre-
quencies of the different types of alleles among the field 
isolates were 68.8  % (126/182) for the Type A, 13.1  % 
(24/182) for the Type B, and 9.28 % (17/182) for the Type 
C (Table 1).
Multiple clones
Mixed-genotype infections or multiplicity of infections 
(MOI) were detected based on the size of the polymor-
phism. Samples were designated as mixed infections 
when the PCR analysis resulted in two or more prod-
ucts of different size or when the RFLP analysis of a sin-
gle PCR band exceeded the size of the uncut PCR band. 
Among all of the samples analysed, 8.2 % (15/182) were 
mixed Pvmsp-3α infections detected by PCR alone. RFLP 
analysis was also carried out to detect mixed infections. 
The total number of multiple clones detected by RFLP 
and PCR was 22.4  % (41/182). However, RFLP analyses 
for detecting multiple clones is challenging and needs to 
be dealt with caution as incomplete digestion may result 
in pseudo bands. The highest number of multiple infec-
tions detected by PCR was in the Chennai (20.5 %) and 
Rourkela (20  %) samples (7/34 and 2/10, respectively) 
(Table 1).
Pvmsp‑3α PCR‑RFLP analysis
Isolates that contained a single allele, as determined by 
PCR, were further analysed by PCR-RFLP, but mixed 
infection cases were excluded. The HhaI restriction 
enzyme showed clear patterns in 139 out of the 167 sam-
ples digested (Additional file 1). In total, 26/167 samples 
(15.5  %) exhibited fragment sizes greater than the PCR 
fragment and inconsistent fragment patterns. These frag-
ments were possibly multiple-clone infections and not 
included in the analysis. The PCR-RFLP patterns from 
141 samples revealed 56 different alleles using the HhaI 
restriction enzyme (Additional file  1). The most preva-
lent alleles were H1 for the Type C haplotype, H2 for the 
Type B haplotype, and H3, H9, H17, H25 and H33 for the 
Type A haplotype, which were present in approximately 
43.5  % (61/140) of the isolates. (Additional file  1: Fig-
ure S1, Additional file 2: Table S1, Additional file 3: Table 
S2). The genotypic combinations of the AluI and HhaI 
enzymes were most diverse in the Type A variant, fol-
lowed by the 1.4-kb variant.
Sequence data
Indian isolates
Sequencing of 20 isolates revealed that, among the Indian 
isolates, the length of the Type A variant ranged from 
1883 to 1938 bp, whereas the length of the Type B variant 
Table 1 Distribution of the three Pvmsp-3α haplotypes among the Indian states based on PCR and RFLP analysis
State Total samples PCR based single clones PCR based  
multiple clones
PCR‑RFLP based single clones PCR‑RFLP 
based MOI
Type A Type B Type C Type A Type B  Type C
Chennai, TN 34 20 4 3 7 19 4 3 1
Delhi 51 41 5 4 1 32 3 3 12
Goa 20 13 2 4 1 12 2 4 1
Car Nicobar 8 8 0 0 0 7 0 0 1
Navi Mumbai, Maha-
rashtra
6 4 0 1 1 4 0 1 0
Nadiad, Gujarat 40 28 7 2 3 23 7 2 5
Rourkela, Orissa 10 6 2 0 2 5 2 0 1
Jabalpur, MP 13 6 4 3 0 5 2 1 5
Total 182 126 24 17 15 107 20 14 26
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ranged from 1452 to 1461 bp and the length of the Type 
C variant ranged from 1128 to 1137  bp. Digestion of 
the three variants with HhaI revealed that a 1-kb frag-
ment was conserved in almost all three of the variants 
(Additional file 1). This band was observed to be slightly 
polymorphic on gels following electrophoresis, and 
sequencing data revealed that the fragment size ranged 
between 929 and 989  bp. Very few restriction patterns 
obtained with the AluI enzyme were identical or even 
similar for closely situated geographical regions, which 
indicates that the higher resolution of the bands obtained 
by actual restriction digestion resulted in numerous 
alleles observed among the Indian isolates.
In silico digestion of the nested PCR products with 
AluI and HhaI resulted in msp-3α sequences being cut 
into a range of four to 13 bands for AluI and three to 
eight bands for HhaI. The size and combinations of the 
virtually digested bands and sequence diversity at and 
between cut sites allowed us to distinguish eight AluI and 
HhaI haplotypes among each of the eight sequences in 
the Type A (Fig. 2). For the Type B variant, two AluI and 
three HhaI haplotypes were observed, and for the Type 
C variant, two haplotypes each for AluI and HhaI were 
identified among the sequences.
Pvmsp‑3α sequence comparison
Type A and Type B PCR fragments contained 480 and 
789 bp deletions, respectively, in block-I, whereas block-
II was relatively conserved in the 20 samples (Fig.  3). 
Pvmsp-3α block-II in the 20 samples had 28 single 
nucleotide polymorphisms and sequence data analysis 
revealed 83.59–99.47  % sequence identity among them-
selves, and the average identity of the Indian isolates 
compared with isolates around the world was above 
74 %. All of the sequenced P. vivax isolates examined in 
this study showed greater identity (range, 95–99  %) to 
the previously sequenced isolates from India (GenBank 
accession numbers HQ328853, HQ328854, HQ328855) 
than to sequences from South Asian or other regions 
worldwide. Figure  3 shows alignment of block-II amino 
acid sequences of the Pvmsp-3α protein from the 20 dif-
ferent Indian isolates and the original sequence from the 
Belem strain of P. vivax. The most striking feature of the 
alignment of the different msp-3α blocks was the pres-
ence of numerous polymorphic sites.
A phylogenetic tree of the Pvmsp-3α sequences was 
constructed using the maximum likelihood method 
based on the nucleotide sequences of the Indian isolates 
in this study and isolates from South Asia, Southeast Asia 
and isolates around the world (Fig.  4). Distances were 
calculated using the bootstrap method with nucleotides 
207–2100  bp of the Belem strain (GenBank accession 
number: AF093584). The Indian isolates from the study 
were compared to Belem and Salvador I strains. Among 
the Indian isolates, clustering of Type B was seen while 
Type A and C were more interspersed among the world 
isolates (Fig. 4). The three variants based on PCR length 
polymorphism mainly fell into separate groups, which 
indicates that a similar genotype prevailed in distinct 
geographic areas as a result of similar selection pressure. 
Fig. 2 AluI and HhaI restriction sites of Pvmsp-3α gene using in silico digestion of 20 isolates from Indian sub-continent (drawn according to scale)
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The Indian isolates compared to 80 published gene bank 
Pvmsp-3α  sequences from different geographic loca-
tions, mainly from South Asia, Southeast Asia and a few 
from other geographic locations worldwide. Comparison 
of the Indian isolates to other isolates revealed cluster-
ing into two distinct groups for the Belem and Salvador 
I type. The analysis revealed almost equal distribution 
of the Indian isolates in both the clusters. Some of the P. 
vivax  isolates examined in this study showed 100  % 
identity with strains of South Korea isolates (Gene bank 
accession numbers: EF204158 and EF204163) and greater 
than 99  % similarity to isolates from Thailand, South 
Fig. 3 Alignment of Pvmsp-3α block II translated sequences showing polymorphism among Indian isolates. Dots and dashes represent identical 
residues and deletions, respectively
(See figure on next page.) 
Fig. 4 Phylogenetic relationships among the 20 Indian isolates sequenced and previously known Indian isolates of the Plasmodium vivax merozoite 
surface protein-3α (Pvmsp-3α) gene of the Indian isolates were compared to Belem strain (AF093584) was conducted using MEGA 6.0 using the 
reference strains and the maximum likelihood method, which is based on the Kimura two-parameter distance. Phylogenetic analysis of the Plas-
modium vivax msp-3α gene. The phylogenetic tree for the 100 isolates, including 20 isolates from the present study of Pvmsp-3α, was constructed 
with maximum likelihood method based on the nucleotide sequences of the Indian isolates using the MEGA6 program. Numbers on the branches 
indicate bootstrap proportions (1000 replicates)
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Korea and Myanmar. The remaining isolates were new 
alleles identified in this study.
Discussion
Malaria remains the most devastating global human par-
asitic infection, and in 2015, about 214 million malaria 
cases and an estimated 438,000 malaria deaths were 
reported [52]. Additionally, the incidence of malaria 
in India accounted for 58 % of cases in the South Asian 
region [1]. P. vivax is the most geographically widespread 
human malaria parasite, and it annually accounting for 
70–80 million clinical cases throughout tropical and 
sub-tropical regions worldwide. In India, P. vivax causes 
approximately 42–45 % of all malaria infections [53].
To develop and evaluate suitable novel control strate-
gies against this parasite, it is important to know the 
extent of the polymorphisms that exist in the population. 
Despite more than a century of efforts to eradicate or 
control malaria, parasite diversity and the genetic varia-
bility of the Plasmodium parasites has made it difficult to 
eradicate this disease. The variability in the polymorphic 
markers impairs the effectiveness of antibody repertoires 
generated during previous infections and also hinders 
development and testing of new drugs and malaria vac-
cines [54]. This study was carried out with the intention 
to further understanding of the genetic structure and 
estimate the extent of the diversity that exists in Pvmsp-
3α among the isolates of the Indian subcontinent.
Observations in the present study revealed that Pvmsp-
3α was a highly diverse and polymorphic marker among 
the field isolates in India. Analysis of 182 field isolates 
collected from eight different locations showed differ-
ent epidemiological patterns, which indicated extensive 
and diverse variation. A high degree of allelic diversity 
previously reported by Kim et  al. [20] among the iso-
lates of Kolkata (India), an area with low transmission 
of malaria, supports the highly diverse and polymorphic 
nature of Pvmsp-3α among Indian isolates. It is inter-
esting to note that there was no significant difference in 
the observed level of diversity among the isolates of low 
and high endemic regions of the Indian sub-continent. 
Similar observations of high diversity among isolates of 
low-endemic areas in Thailand were made by Cui et  al. 
[45]. It is suspected that either highly virulent isolates are 
not present despite high diversity or the malaria control 
measures in such regions are more effective for restrict-
ing the incidence to a low level.
All three of the Pvmsp-3α PCR variants (Type A, B and 
C) observed worldwide were present among the field 
isolates, although with varied frequencies in the differ-
ent geographical regions. The largest size variant (Type 
A) occurred at the highest frequency in all samples of 
natural P. vivax populations in India, and the frequencies 
observed were similar to the previously reported global 
frequencies. The difference in the proportion of the Type 
A and C variants in the population might have been due 
to the deletions found in the smaller length variants, 
which might have caused a loss of fitness for the parasites 
that carried the variants [26]. However, these genotypes 
may occur in the population to balance any fitness cost 
associated with large deletions within Pvmsp-3α [55]. 
Block-I exhibits maximum sequence variability in this 
region, acts as a placeholder to mimic the larger length 
variant [56] and also confers a selective advantage to the 
parasite, i.e., evasion of preexisting immune responses. 
The observation that block-II exhibits only slight varia-
tion in size and very little polymorphism that is limited to 
certain portions indicates that it plays an important role 
in the formation of the protein structure. The Type B and 
Type C variants exhibited minimal sequence diversity 
and differed from each other in the nucleotide sequences 
that form the beta helix turn.
Analysis of the isolates from eight regions of the Indian 
sub-continent indicated that diversity was not linked 
to geographical region and a high level of diversity was 
observed within the same region. New alleles identi-
fied in the Indian isolates demonstrated high variabil-
ity among the field isolates. The high allelic diversity of 
Pvmsp-3α has also been reported in other regions of the 
globe, including South Asia, Southeast Asia, PNG [46] 
and Latin America [55], including Peru [57] and Colom-
bia [58]. Some of the identified alleles are consistent with 
those from earlier reports, which indicate global distribu-
tion of certain parasite genotypes [59]. Based on msp-3α 
data, the existence of a common allelic composition in 
different parts of the globe indicates the presence of a 
single random-mating population of P. vivax across the 
globe with no geographical sub-structuring. However, 
this may not be true as new molecular approaches such 
as microsatellite and mitochondrial studies have been 
used to assess P. vivax quantifying parasite diversity and 
population structure [16, 60–62]. HhaI digestion revealed 
56 alleles and H1 allele was most prominent in the Indian 
sub-continent and was seen in the Type C variant among 
the Indian isolates. H1 allele in these variants has been 
reported from other regions of the world, including those 
from India [21, 63, 64].
Simultaneous infection of a host by more than one 
strain of the same parasite is common in malaria and is 
partially correlated with transmission intensity levels. 
For P. vivax malaria, the estimated proportion of mixed-
strain infections in PNG is 65  % [65], compared with 
43 % reported in India [66]. In recent studies in the Kol-
kata region of India, 10.6 % of recorded cases were mul-
tiple infections [20]. In the present study, 8.2 % of cases 
were multiple infections based on PCR detection and 
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22 % based on PCR-RFLP of Pvmsp-3α sequences. RFLP 
analyses for detecting multiplicity of infection may not 
be completely reliable as incomplete digestion lead to 
spurious results. Restriction with multiple enzymes may 
be helpful in detecting multiple clones by RFLP. Fur-
ther, microsatellite (MS) markers and SNP’s are reliable 
and important tools for studying multiplicity of infection 
(MOI) of malaria parasite infections [28, 67, 68].
Several studies reported extensive microsatellite diver-
sity and high multiplicity of infection in P.  vivax  in 
regions of moderate endemicity [61]. The increased 
multiplicity of P. vivax infection is attributable to the 
biological features of the P. vivax parasite, such as early 
gametocytogenesis and relapse [35]. Moreover, the mul-
tiplicity of infections is likely to facilitate genetic recom-
bination of parasites, and the generation of novel strains 
[45].
The observed high level of Pvmsp-3α diversity among 
the field isolates was further supported by sequencing 
data, which revealed that the different genotypes of the 
sequenced isolates were found throughout the differ-
ent geographical areas. In particular, the most common 
variant (Type A) displayed the maximum diversity, which 
was expected because of the presence of an intact block-
IB in this variant, which is the most variable. However, in 
the smaller length variants (Type B and C), block-IB was 
either completely or partially deleted, thereby reducing 
the diversity.
Twenty samples were sequenced, and the restric-
tion sites were analysed. No two resulting AluI or HhaI 
restriction banding patterns were similar in the Type A 
haplotype, which indicated the extent of the variabil-
ity. Most of the isolates sequenced revealed new alleles. 
Based on the restriction site analysis of the sequenced 
isolates, it can be concluded that each of the Type A hap-
lotypes isolated was a different allele. However, when 
restriction sites of the sequenced Type B haplotype 
(identical pattern on the gel) were analysed, the restric-
tion pattern differed slightly in terms of band size. How-
ever, the Type C fragment restriction pattern analysis of 
the sequenced fragment revealed a similar pattern, thus 
indicating reduced variability in the smaller types. The in 
silico restriction site analysis of the published Pvmsp-3α 
sequences from various geographical regions was car-
ried out using restriction mapping software. The virtual 
restriction patterns obtained with either the HhaI or 
AluI enzymes were not analogous to isolates from a sin-
gle region or close geographical regions, which indicated 
that higher resolution of the bands obtained by actual 
restriction mapping could result in numerous alleles, as 
was obtained from the Indian isolates. This finding signi-
fies the importance of sequence data as a source for esti-
mating the exact variability and its extent among isolates 
from other areas globally. As reported earlier, higher 
levels of sequence polymorphism were observed in the 
region closer to the central alanine-rich domain [28, 40, 
48].
Pvmps-3α is an essential polymorphic marker for stud-
ying the population structure of P. vivax. Numerous stud-
ies from various regions have been carried out to identify 
the number of Pvmsp-3α alleles using the PCR-RFLP 
method [20, 21, 32–37, 39–43]. Several investigators have 
advocated for this method as a means of identifying the 
variations available in this allele. However, based on the 
in silico digestion, AluI results in complicated patterns 
may not be a good enzyme for PCR-RFLP purpose [28]. 
Virtual digestion of Pvmsp-3α sequences revealed greater 
variability in terms of the fragment sizes obtained, which 
was not resolved easily on a gel and could result in reach-
ing a biased conclusion regarding the number of alleles. 
Moreover, the results may vary depending on the elec-
trophoresis conditions. As proposed by Rice et  al. [28], 
sequencing may be a better option to determine the 
sequence-level genetic diversity of the pvmsp-3α gene. 
Therefore, sequencing analysis is advocated for analys-
ing the extent of the variability generated by the parasite 
to evade the host immune system and impart a survival 
advantage to the parasite [28, 69].
PvMSP-3α is a potentially important vaccine candidate 
expressed on the surface of the merozoite in the para-
site [70]. Dual role for PvMSP-3α in both the immunity 
and pathogenesis of malaria has been suggested [71]. 
PvMSP-3α is known to elicit a pronounced antibody 
response against clinical malaria infections reported 
from PNG [46]. Additionally, it has been established 
that naturally acquired antibodies against the C-terminal 
block-II of PvMSP3α are associated with protection from 
symptomatic vivax malaria [46].
There is limited information available regarding 
PvMSP3α sequences from India. Sequence polymor-
phisms in Indian isolates were mainly clustered at the 
5′ regions of the marker, as was seen in other isolates 
worldwide. However, block-II (residues 434–687aa of 
Belem strain), the region of the alanine-rich core dis-
plays less variability. In an earlier study phylogenic analy-
sis based on sequence variation of 237 world sequences 
of PvMSP-3α block II region resulted in three robust clus-
ters suggesting extensive gene flow between populations. 
However these clusters did not reveal any geographi-
cal structure. The phylogenic grouping was influenced 
by sequence variations of two motif (motif I: MSELEK/
LSKLEE and motif II: TAANVVKD/KEATAAKL) which 
suggested selective pressure on these motifs [38].
In the Belem strain the motifs I and II correspond to 
position 529–534aa and 576–583aa respectively [26]. 
Among the Indian isolates, motif I was represented by 
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MSELEK sequence in all the twenty isolates, while motif 
II exhibited both the sequences at different frequencies. 
One of the Indian isolates however represented a recom-
binant type of motif with an amino acid sequence of 
TEANVAKL, which was seen in the Goan isolate.
Comparison with published nucleotide and protein 
sequences in NCBI and PlasmaDB using phylogenetic 
trees of Pvmsp-3α revealed that most subtypes were new 
alleles. Two distinct clusters, one which included Belem 
type and the other Salvador I type were formed when the 
Indian isolates were compared with other isolates world-
wide. Genotypes from different geographical areas were 
distributed in both clusters, which revealed no convincing 
evidence of geographical grouping based on this marker.
Conclusions
The present study indicates a high degree of genetic 
diversity in clinical Pvmsp-3α isolates and is remarkably 
diverse, even within limited geographical areas of the 
Indian subcontinent. The high prevalence of mixed-clone 
infections revealed by this marker in the Indian sub-con-
tinent likely resulted from a high transmission rate and 
tropical climate, which offers a suitable environment for 
vector breeding. The extensive allelic diversity demon-
strates Pvmsp-3α to be a very useful molecular marker 
for distinguishing field isolates. However, further inves-
tigation is required to elucidate the diversity and expres-
sion of the C-terminal conserved region in field isolates, 
which will help reveal the potential of this gene as a vac-
cine candidate.
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